Acta Pharmaceutica (Sep 2016)

PF573,228 inhibits vascular tumor cell growth, migration as well as angiogenesis, induces apoptosis and abrogates PRAS40 and S6RP phosphorylation

  • Mabeta Peace

DOI
https://doi.org/10.1515/acph-2016-0031
Journal volume & issue
Vol. 66, no. 3
pp. 399 – 410

Abstract

Read online

PF573,228 is a compound that targets focal adhesion kinase (FAK), a non-receptor protein kinase, which is over-expressed in various tumors. The aim of this study was to evaluate the effects of PF573,228 on the cells derived from mouse vascular tumors, namely, endothelioma cells.

Keywords